At a glance
- Originator Merck Sante
- Class Antihyperglycaemics; Antihyperlipidaemics; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Hyperlipidaemia